Cancer News and Research

Latest Cancer News and Research

Oophorectomy could increase colorectal cancer risk in both pre- and postmenopausal women

Colorectal cancer may rise in women who have their ovaries removed, according to new research.

5 May 2016

Sexually-assaulted women more likely to develop variety of medical conditions

Researchers have found that a variety of conditions are more common in women before and after sexual assault.

5 May 2016

Certain sugars in the body play key role in colitis, colon cancer development

An Oklahoma Medical Research Foundation scientist has discovered that certain sugars produced by the body play an important role in the development of colitis and, ultimately, colon cancer. The new finding could potentially lead to therapies for ulcerative colitis, Crohn's disease and colon cancer.

5 May 2016

Loyola researchers detect tumor gene that may help predict survival outcomes in mouth cancer patients

Loyola researchers have identified a tumor gene that may help to predict survival outcomes in patients with cancer of the mouth and tongue.

5 May 2016

Researchers develop computer model to reveal how antibiotic-resistant microbes develop and spread

Researchers from the Scientific Research Institute of Physical-Chemical Medicine, MIPT, the company M&S Decisions and the research department of Yandex have built a computer model of the interaction between different bacteria, and between bacteria and the gut wall.

5 May 2016

Proton therapy offers new hope to patients with inoperable tumors

An enormous high tech machine is providing new hope to patients across the country with inoperable tumors. Proton therapy is a precise radiation technique that reduces the side effects often accompanied by traditional treatment options. Thanks to this remarkable technology, a new proton therapy center at UF Health Cancer Center - Orlando Health is saving the eyesight of a new mother who was diagnosed with a tumor behind her eye during her second trimester of pregnancy.

5 May 2016

Bayer-new phase 3 liver cancer data

Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.

4 May 2016

OGT launches Cytocell FISH probes for glial tumours

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.

4 May 2016

Anaesthesia services given seal of approval by Royal College

The quality of anaesthesia services at Sheffield Teaching Hospitals has been recognised with accreditation from the Royal College of Anaesthetists.

4 May 2016

University hospital in Finland invests in digital pathology from Sectra

Kuopio University Hospital will be Finland's first fully digital pathology department following its investment in Sectra's IT solution for efficient storage, review and sharing of digital pathology images. The Diagnostic Imaging Center at Kuopio University Hospital is thereby extending its existing solution for handling radiology images (PACS) to also include pathology images. This enables in-depth cooperation between the hospital's radiologists and pathologists; two of the key functions in effective clinical care.

4 May 2016

BMJ experts reveal medical error as third main cause of death in the U.S

Medical error is the third leading cause of death in the US after heart disease and cancer, say experts in The BMJ today.

4 May 2016

Researchers detect five new genes that increase endometrial cancer risk in women

An international collaboration of researchers has identified five new gene regions that increase a woman's risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.

4 May 2016

LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

The University of Southern California Roski Eye Institute researchers and clinicians published results of the largest population-based study of adult Latinos and age-related macular degeneration (AMD) in the National Eye Institute-funded "Los Angeles Latino Eye Study." The study, published in JAMA Ophthalmology, is the first to analyze the risk and prevalence of early and late stage AMD and its impact on quality of life for older Latinos.

4 May 2016

Report: Protecting eyes from UV exposure not high priority for Americans

Three-quarters of Americans are concerned about potential eye problems from the sun's ultraviolet rays, yet only 31 percent protect their eyes with sunglasses or other UV-protective eyewear every time they go outside, according to a new nationwide survey released today. The report by The Vision Council, based on a survey of more than 10,000 adults, finds 34 percent of adults have experienced symptoms of prolonged UV exposure, such as eye irritation, trouble seeing, and red or swollen eyes.

4 May 2016

LBDA director emphasizes need for open national dialog on dementia at ADRD Summit

Angela Taylor, Director of Programs for The Lewy Body Dementia Association recently addressed attendees at the National Institutes of Health's 2016 Alzheimer's Disease-Related Dementia Summit on the need for an open national dialog on changing the nomenclature frequently used to describe different forms of dementia.

4 May 2016

Study reveals new cell-signaling pathway that detects chromosome missegregation

A recent research study at The Hormel Institute, University of Minnesota is providing insight into the regulation of chromosome segregation and the mechanisms used by cells to prevent them from forming tumors.

4 May 2016

Long-term use of herbal remedies may not guarantee safety

Millions of people around the world use herbal health remedies, following a tradition that began millennia ago. Many believe that herbs are safe because they have been used for many years, but researchers from Baylor College of Medicine and Stony Brook University are raising awareness that long-term use of herbal remedies is no guarantee of their safety. The invited commentary appears in EMBO reports.

4 May 2016